CytomX Therapeutics Inc
NASDAQ:CTMX

Watchlist Manager
CytomX Therapeutics Inc Logo
CytomX Therapeutics Inc
NASDAQ:CTMX
Watchlist
Price: 1.03 USD 1.98% Market Closed
Market Cap: 80.5m USD
Have any thoughts about
CytomX Therapeutics Inc?
Write Note

CytomX Therapeutics Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CytomX Therapeutics Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
CytomX Therapeutics Inc
NASDAQ:CTMX
Total Other Income
-$11k
CAGR 3-Years
54%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$4.6B
CAGR 3-Years
12%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$302m
CAGR 3-Years
76%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$578m
CAGR 3-Years
81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$65.2m
CAGR 3-Years
N/A
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
$6m
CAGR 3-Years
-49%
CAGR 5-Years
-35%
CAGR 10-Years
8%

See Also

What is CytomX Therapeutics Inc's Total Other Income?
Total Other Income
-11k USD

Based on the financial report for Sep 30, 2024, CytomX Therapeutics Inc's Total Other Income amounts to -11k USD.

What is CytomX Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
41%

Over the last year, the Total Other Income growth was 73%. The average annual Total Other Income growth rates for CytomX Therapeutics Inc have been 54% over the past three years , 41% over the past five years .

Back to Top